Hints and tips:
Related Special Reports
...Fruergaard Jørgensen said that a tablet product from the acquisition last year of a Canadian biotech, Inversago, could be a scalable weight-loss pill and alternative to the popular GLP-1-based drugs....
...Lars Fruergaard Jørgensen, Novo Nordisk’s chief executive, told the Financial Times that to make a “dent” in a condition such as obesity, the company needed to treat many more than just the millions of patients...
...Dan Jørgensen, the Danish climate and development minister, said that to maintain citizens’ support for the Green Deal, the EU needed to “do our homework” and ensure that climate policy was integrated....
...Lars Fruergaard Jørgensen, the chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid Dkr68mn (£7.8mn) last year....
...Lars Fruergaard Jørgensen, chief executive of Novo Nordisk, Europe’s largest pharma group by market capitalisation, was paid DKr68mn (£7.8mn) last year....
...But a focus on prevention would take them a “step earlier”, said Jørgensen, while giving Novo Nordisk a new edge in an increasingly competitive market....
...Dan Jørgensen: I definitely think it’s been a positive experience, in the sense that there really is a growing momentum in the world [for] climate financing....
...Jørgensen wants to shift from a social media debate to a medical discussion with doctors about the benefits....
...Sanders wrote to Lars Fruergaard Jørgensen, chief executive of the Denmark-based drugmaker, to inform him the US committee that oversees healthcare was investigating “the outrageously high prices” the company...
...“The global transition away from oil and gas will have profound implications for developing countries that are economically dependent on fossil fuel exports,” said Jørgensen....
...Jørgensen apologised and said the failure to disclose sponsorship of a training course was a “mistake”....
...Jørgensen said: “I think most healthcare systems would acknowledge that if you cater for BMI with a certain level of comorbidities, there is a very strong case.”...
...Jørgensen said his view was the new target needed to take in public, private and concessional money....
...But Jørgensen, who has been floated as potential future EU climate commissioner, sees the accession of Ukraine and others not as a hindrance to climate ambition but “as a chance”....
...and larger base,” Jørgensen said....
...Chief executive Lars Fruergaard Jørgensen told the Financial Times this month that it was assessing deals for biotech companies with mid-stage drugs....
...Those efforts contributed to chief executive Lars Fruergaard Jørgensen being named the FT’s Person of the Year in 2023....
...Jørgensen, president of EFPIA, the industry association, spoke on Friday as he launched a study outlining the dramatic impact the plan would have — creating what he called a “negative ecosystem”....
...Jørgensen said the two companies had competed against each other for 100 years in diabetes....
...Read a transcript of this episode on FT.com...
...Innovation is moving to the US,” Lars Fruergaard Jørgensen, president of Efpia and chief executive of Novo Nordisk, the EU’s most valuable drugmaker, told the FT....
...“So many Americans and Republicans still support the principles of Ronald Reagan even when they’re not being advocated to them,” Marc Thiessen, a former speechwriter for George W Bush said during a panel...
...for the death of his ex-wife, Nicole Brown, and her friend, Ronald Goldman....
International Edition